U.S. markets open in 6 hours 48 minutes

INVO Bioscience, Inc. (INVO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.8800-0.0400 (-1.02%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Hammer

Hammer

Previous Close3.9200
Open3.8700
Bid0.0000 x 1000
Ask0.0000 x 800
Day's Range3.8601 - 4.0500
52 Week Range2.9000 - 12.3000
Volume69,687
Avg. Volume1,995,024
Market Cap40.446M
Beta (5Y Monthly)-1.13
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateMar 30, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • INVO Bioscience Signs Partnership Agreement with Lyfe Medical to Establish INVOcell Clinic in Northern California
    PR Newswire

    INVO Bioscience Signs Partnership Agreement with Lyfe Medical to Establish INVOcell Clinic in Northern California

    INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with infertility, today announced the execution of a partnership agreement with Lyfe Medical, LLC ("Lyfe Medical") focused on the expansion of the INVOcell solution in Northern California (with an area population of ~8 million people).

  • INVO Bioscience to Present at Tribe Public Event on April 13, 2021
    PR Newswire

    INVO Bioscience to Present at Tribe Public Event on April 13, 2021

    INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, announced today that Steve Shum, CEO of INVO Bioscience, will present at Tribe Public's Webinar Presentation and Q&A Event titled "Democratizing Infertility - A Severely Underserved Global Market." The Event is scheduled to begin at 8:30 am Pacific/11:30 am Eastern on Tuesday, April 13, 2021.

  • INVO Bioscience Reports 2020 Financial Results
    PR Newswire

    INVO Bioscience Reports 2020 Financial Results

    INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today announced financial results for the year ended December 31, 2020.